ArticleLeukemia & lymphoma2024
Cost-effectiveness of adding quizartinib to induction chemotherapy for patients with
Jan Philipp Bewersdorf et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
2 papers cite it
this papertrialcites it